|Manufacturer:||Pfizer Ltd manufactures Minidiab.|
|Uses:||The uses of Minidiab include:|
Minidiab is used for: Treating patients with type 2 diabetes who cannot control blood sugar levels by diet and exercise alone. It may be used alone or with other antidiabetic medicines.
Glipizide is in a class of drugs called sulfonylureas. It is used to help control blood sugar levels.
Glipizide is used to treat type 2 diabetes along with diet, exercise, and insulin therapy, if necessary.
Decreases blood glucose by stimulating insulin release from pancreas and by increasing tissue sensitivity to insulin.
Minidiabl is an oral antidiabetic medication used to treat type 2 (non-insulin-dependent) diabetes. In diabetics either the body does not make enough insulin or the insulin that is produced no longer works properly.
There are actually two forms of diabetes: type 1 insulin-dependent and type 2 non-insulin-dependent. Type 1 usually requires insulin injections for life, while type 2 diabetes can usually be treated by dietary changes and/or oral antidiabetic medications such as Glipizide. Apparently, Glipizide controls diabetes by stimulating the pancreas to secrete more insulin. If you suffer from type 1 diabetes, you will need to use insulin and will not be able to use Glipizide. Occasionally, type 2 diabetics must take insulin injections on a temporary basis, especially during stressful periods or times of illness.